Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026)
Korro Bio (KRRO) posted Other Accumulated Expenses of $175000.0 for Q1 2026, up 150.0% on a QoQ basis from $70000.0 in Q4 2025, and down 64.5% year-over-year from $493000.0 in Q1 2025.
Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
Korro Bio's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $175000.0 for Q1 2026.
- Quarterly Other Accumulated Expenses fell 64.5% year-over-year to $175000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $175000.0 (down 64.5% YoY) and the FY2025 annual result came in at $70000.0, down 74.73% from the prior year.
- Other Accumulated Expenses was $175000.0 for Q1 2026 at Korro Bio, up from $70000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $493000.0 in Q1 2025 and bottomed at $70000.0 in Q4 2025.
- A 5-year average of $231583.3 and a median of $196500.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Peak annual rise in Other Accumulated Expenses reached 252.14% in 2025, while the deepest fall reached 74.73% in 2025.
- Korro Bio's Other Accumulated Expenses stood at $207000.0 in 2022, then soared by 115.94% to $447000.0 in 2023, then sank by 38.03% to $277000.0 in 2024, then tumbled by 74.73% to $70000.0 in 2025, then surged by 150.0% to $175000.0 in 2026.
- Business Quant data shows KRRO's Other Accumulated Expenses at $175000.0 in Q1 2026, $70000.0 in Q4 2025, and $111000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 130,000.00 |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 247,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 296,000.00 |
| Dec 31, 2019 | 170,000.00 |
| Sep 30, 2019 | 16.00 Mn |
| Dec 31, 2018 | 161,000.00 |